InvestorsHub Logo
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: someconcerns post# 157613

Sunday, 08/28/2016 3:18:24 PM

Sunday, August 28, 2016 3:18:24 PM

Post# of 403230
Sc - thanks - very good report. Do you have a link for this report?

For early biotechs investors like CTIX - this is very important

"Phase II transition success rate (30.7%, n=3,862) was substantially lower than Phase I, and the lowest of the four phases studied.
As this is generally the first stage where proof-of-concept is deliberately tested in human subjects, Phase II consistently had the lowest success rate of all phases.
This is also the point in development where industry must decide whether to pursue the large, expensive Phase III studies and may decide to terminate development for multiple reasons including commercial viability"

CTIX does not have any drug in P3 trial - B-ABSSI P3 trial is in transition phase since Oct 2014 - not yet started

This may also be reflected in current valuations. B showed very good results in P2 but CTIX is dragging its feet and has not officially started the P3 and not sure when they will start (maybe not till P3 for P or B-OM)

Till that time it is just a promising company that may give good end results in few years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News